Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynne P Yao

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Birth Defects Research. Part A, Clinical and Molecular Teratology|July 30, 2015
Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug productsMelissa S Tassinari, Leyla Sahin, Lynne P Yao
Pediatric Nephrology (Berlin, Germany)|November 6, 2014
Defining new surrogate markers for CKD progressionH William Schnaper, Susan L Furth, Lynne P Yao
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 19, 2012
The role of immune tolerance induction in restoration of the efficacy of ERT in Pompe diseaseEmanuela Lacaná, Lynne P Yao, Anne R Pariser, et al.
Therapeutic Innovation & Regulatory Science|July 5, 2017
Pediatric Medicine Development: An Overview and Comparison of Regulatory Processes in the European Union and United StatesDobromir Penkov, Paolo Tomasi, Irmgard Eichler, et al.
British Journal of Clinical Pharmacology|November 29, 2025
Paediatric developmental safety and the ICH E11A extrapolation of safetyGilbert J Burckart, Susan M Abdel-Rahman, Gelareh Abulwerdi, et al.
Clinical Pharmacology and Therapeutics|December 20, 2018
Renal Clearance in Newborns and Infants: Predictive Performance of Population-Based Modeling for Drug DevelopmentJian Wang, Shaun S Kumar, Catherine M Sherwin, et al.
Clinical Pharmacology and Therapeutics|February 8, 2020
Exposure-Response Assessment in Pediatric Drug Development Studies Submitted to the US Food and Drug AdministrationYifei Zhang, Yaning Wang, Mona Khurana, et al.
Clinical Pharmacology and Therapeutics|January 27, 2020
Scientific and Regulatory Considerations for an Ontogeny Knowledge Base for Pediatric Clinical PharmacologyGilbert J Burckart, Shirley Seo, Aaron C Pawlyk, et al.
Clinical Pharmacology and Therapeutics|July 23, 2020
Creatinine-Based Renal Function Assessment in Pediatric Drug Development: An Analysis Using Clinical Data for Renally Eliminated DrugsYifei Zhang, Catherine M Sherwin, Daniel Gonzalez, et al.
Pediatrics|October 26, 2011
Extrapolation of adult data and other data in pediatric drug-development programsJulia Dunne, William J Rodriguez, M Dianne Murphy, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Birth Defects Research. Part A, Clinical and Molecular Teratology|July 30, 2015
Assessing congenital malformation risk from medications used in pregnancy: The contribution of NBDPS in pregnancy labeling of prescription drug productsMelissa S Tassinari, Leyla Sahin, Lynne P Yao
Pediatric Nephrology (Berlin, Germany)|November 6, 2014
Defining new surrogate markers for CKD progressionH William Schnaper, Susan L Furth, Lynne P Yao
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics|January 19, 2012
The role of immune tolerance induction in restoration of the efficacy of ERT in Pompe diseaseEmanuela Lacaná, Lynne P Yao, Anne R Pariser, et al.
Therapeutic Innovation & Regulatory Science|July 5, 2017
Pediatric Medicine Development: An Overview and Comparison of Regulatory Processes in the European Union and United StatesDobromir Penkov, Paolo Tomasi, Irmgard Eichler, et al.
British Journal of Clinical Pharmacology|November 29, 2025
Paediatric developmental safety and the ICH E11A extrapolation of safetyGilbert J Burckart, Susan M Abdel-Rahman, Gelareh Abulwerdi, et al.
Clinical Pharmacology and Therapeutics|December 20, 2018
Renal Clearance in Newborns and Infants: Predictive Performance of Population-Based Modeling for Drug DevelopmentJian Wang, Shaun S Kumar, Catherine M Sherwin, et al.
Clinical Pharmacology and Therapeutics|February 8, 2020
Exposure-Response Assessment in Pediatric Drug Development Studies Submitted to the US Food and Drug AdministrationYifei Zhang, Yaning Wang, Mona Khurana, et al.
Clinical Pharmacology and Therapeutics|January 27, 2020
Scientific and Regulatory Considerations for an Ontogeny Knowledge Base for Pediatric Clinical PharmacologyGilbert J Burckart, Shirley Seo, Aaron C Pawlyk, et al.
Clinical Pharmacology and Therapeutics|July 23, 2020
Creatinine-Based Renal Function Assessment in Pediatric Drug Development: An Analysis Using Clinical Data for Renally Eliminated DrugsYifei Zhang, Catherine M Sherwin, Daniel Gonzalez, et al.
Pediatrics|October 26, 2011
Extrapolation of adult data and other data in pediatric drug-development programsJulia Dunne, William J Rodriguez, M Dianne Murphy, et al.
Pageof 2